Home » CARACO RECEIVES FINAL APPROVAL TO MARKET GENERIC ULTRACET
CARACO RECEIVES FINAL APPROVAL TO MARKET GENERIC ULTRACET
Caraco Pharmaceutical Laboratories has received final FDA approval for its abbreviated new drug application for tramadol HCl with acetaminophen in tablet form. Caraco's product is the generic equivalent of Ortho McNeil Pharmaceutical's Ultracet, which is indicated for the short-term management of acute pain.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May